Markets › United States › NAS › BSEM

BioStem Technologies, Inc.

NAS:BSEMHealth TechnologyNASDAQ:INDSnasdaq_composite

$1.54−26.32%At closeAt close · Tue 20 Oct · ≈ AED 5.66 · Market cap — · Next earnings Tue 17 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	41.8%	58.5%	83.6%	91.1%	80.0%	93.1%	+13.2 pts
Operating margin	−67.7%	−33.0%	−68.1%	−46.6%	44.7%	−1.5%	−46.1 pts
Net margin	−103.2%	−31.7%	−104.6%	−50.8%	44.5%	−13.9%	−58.4 pts
EBITDA margin	−56.6%	−26.5%	−64.6%	−45.2%	45.1%	−0.6%	−45.7 pts
Return on equity	45.1%	24.7%	176.5%	631.0%	77.5%	−16.8%	−94.3 pts
Return on assets	−93.3%	−50.2%	−201.1%	−58.1%	53.1%	−13.1%	−66.2 pts
Return on capital employed	44.2%	35.9%	170.2%	769.7%	76.8%	−1.7%	−78.5 pts
Debt / equity	−1.0×	−0.9×	−1.3×	−3.6×	0.1×	0.1×	−22.5%
Debt / assets	209.1%	183.8%	145.6%	32.7%	7.5%	6.6%	−0.9 pts
Interest coverage	−3.1×	0.0×	−10.0×	−11.1×	50.0×	0.0×	−100.0%
Current ratio	0.1×	0.1×	0.2×	0.8×	2.9×	4.1×	+42.6%
Quick ratio	0.0×	0.1×	0.2×	0.8×	2.8×	3.9×	+38.2%
Cash ratio	0.0×	0.1×	0.1×	0.0×	1.3×	2.7×	+115.6%
Asset turnover	0.9×	1.6×	1.9×	1.1×	1.2×	0.9×	−20.6%
Inventory turnover	2.4×	5.5×	2.8×	2.3×	7.7×	1.1×	−85.2%
Receivables turnover	203.1×	14.5×	184.8×	1.5×	2.9×	4.8×	+68.1%
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—